AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-15864494_ITM" title="Facts and information about Sex differences in lung Ca highlighted.(FYI)">Sex differences in lung Ca highlighted.(FYI)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Sex differences in lung Ca highlighted.(FYI)
A report on a meeting about sex differences in lung cancer that was sponsored by the Society for Women's Health Research is available on the Internet at www.womenshealthresearch.org/events/sam_houston.htm. The report ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Sex differences in lung Ca highlighted.(FYI)(Brief Article)
- Magazine article from: Family Practice News December 15, 2005 700+ words
A report on a meeting about sex differences in lung cancer that was sponsored by the Society for Women's Health Research is available on the Internet at www.womenshealthresearch...
- Lung Ca May Reverse Drop in Cancer Rates.(Brief Article)
- Magazine article from: Family Practice News LINDSAY, HEATHER June 15, 1999 700+ words
Any rejoicing over recent declines in cancer incidence and mortality may be premature. Lung cancer remains the number one cause of cancer death for both men and women. The popularity of smoking could cause enough lung cancer cases to send overall cancer rates up again, according to Dr. Phyllis A.
- Lung Ca in Women With HIV.(Statistical Data Included)
- Magazine article from: Family Practice News April 1, 2000 700+ words
The risk of lung cancer is twice as high in HIV-infected women as in seronegative women who are at risk for HIV, based on the results of a small prospective study presented at a conference on Retroviruses and Opportunistic Infections. Ruby Phelps of the Centers for Disease Control and Prevention
- Hormone therapy raises lung ca death risk.(ACROSS SPECIALTIES)
- Magazine article from: Clinical Psychiatry News Dales, Mary Jo M. July 1, 2009 700+ words
ORLANDO -- Hormone therapy with estrogen plus progestin for more than 5 years increased the risk of death in women diagnosed with non-small cell lung cancer, based on secondary analyses from the Women's Health Initiative reported at the annual meeting of the American Society of Clinical Oncology.
- Radiofrequency ablation improves lung ca survival.(Pulmonary Medicine)(cancer)
- Magazine article from: Internal Medicine News Tucker, Miriam E. May 1, 2008 700+ words
Senior Writer WASHINGTON -- Radiofrequency ablation resulted in 70% survival at 2 years in a study of 244 lung cancer patients. "Radiofrequency ablation is minimally invasive, with a high local success rate. It is a curative treatment in nonsurgical patients," Dr. Thierry de Baere said at the
- Gene Therapy for Lung Ca.
- Magazine article from: OB GYN News Kubetin, Sally Koch July 15, 2000 700+ words
Gene therapy administered via bronchoalveolar lavage benefited some patients with bronchoalveolar lung cancer, Dr. David Carbone said at the annual American Cancer Society science writers seminar. Bronchoalveolar lung carcinoma spreads along the alveoli and bronchiolar surfaces, making it nearly
- CT not advised for lung Ca screening.(Pulmonary Medicine)(computed...
- Magazine article from: Internal Medicine News Finn, Robert October 15, 2007 700+ words
In a controversial move, the American College of Chest Physicians has formally recommended against the use of low-dose helical CT scanning for general lung cancer screening, even in high-risk populations, except in the context of clinical trials. The ACCP also recommended against the use of serial
- Antiangiogenesis drug gets nod for unresectable lung ca.(Pulmonary Medicine)
- Magazine article from: Internal Medicine News Mechcatie, Elizabeth November 15, 2006 700+ words
The Food and Drug Administration last month gave physicians a new tool in the battle against lung cancer, approving the antiangiogenesis agent bevacizumab in combination with chemotherapy as an initial treatment of unresectable non-small cell lung cancer. "While this is not a silver bullet or